Influence of immunoglobulin light chain dimers on the results of the quantitative nephelometric assay

Clinical Laboratory

Volumn 57, Issue 1-2, 2011, Pages 53-57

  Li, Chang ^a   Geng, Honglian ^a   Yang, Zaixing ^a   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Light chain dimers; Quantitative nephelometric assay

Indexed keywords

DIMER; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MERCAPTOETHANOL; MONOMER;

ARTICLE; CLINICAL ARTICLE; HUMAN; MULTIPLE MYELOMA; NEPHELOMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; QUANTITATIVE ANALYSIS; URINALYSIS; DIMERIZATION; METHODOLOGY; OXIDATION REDUCTION REACTION; PHOTOMETRY; URINE;

DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; NEPHELOMETRY AND TURBIDIMETRY; OXIDATION-REDUCTION;

EID: 79953820931     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Singhal S, Stein R, Vickrey E, Mehta J. The serum-free light chain assay cannot replace 24-hour urine protein estimation in patients with plasma cell dyscrasias [letter]. Blood 2007; 109: 3611-2. (Pubitemid 46572562)
2. Abraham RS, Charlesworth MC, Owen BA, et al. Trimolecular complexes of lambda light chain dimmers in serum of a patient with multiple myeloma. Clin Chem 2002;48:1805-11.
3. Kaplan B, Ramirez-Alvarodo M, Dispenzieri A, et al. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeoma: a pilot study of intact and truncated forms of light chains and their charge properties. Clin Chem Lab Med 2008;46:335-41. (Pubitemid 351317768)
4. Tate JR, Mollee P, Dimeski D, Carter AC, Gill D. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clin Chim Acta 2007;376:31-6.
5. Bricon TL, Bengoufa D, Benlakehal M, Bousquet B, Erlich D. Urinary free light chain analysis by the Freelite® immunoassay: a preliminary study in multiple myeloma. Clin Biochem 2002; 35:565-7. (Pubitemid 35462133)
6. Schuurman J, Perdok GJ, Gorter AD, Aalberse RC. The interheavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. Mol Immonol 2001;38:1-8. (Pubitemid 32718637)
7. Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA. Diagnostic performance of quantitative κ and λ free light chain assays in clinical practice. Clin Chem 2005;51:878-81. (Pubitemid 40577925)
8. Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005;106:812-7. (Pubitemid 41076419)
9. Drayson M, Tang LX, Drew R, Mead GP, Smith HC, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97:2900-2.
10. Hill PG, Forsyth JM, Rai B, Mayne S. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clin Chem 2006;52:1743-8. (Pubitemid 44330709)